Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Logothetis

Showing results (61-70 of 251) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinomaLance C Pagliaro, Randall E Millikan, Shi-Ming Tu, et al.
Journal of the National Cancer Institute|January 19, 2019
Radium 223-Mediated Zonal Cytotoxicity of Prostate Cancer in BoneEleonora Dondossola, Stefano Casarin, Claudia Paindelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancerRandall E Millikan, Sijin Wen, Lance C Pagliaro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2004
Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumorsKarim Fizazi, Stéphane Culine, Andrew Kramar, et al.
Endocrine-Related Cancer|May 6, 2020
Fibroblast growth factors signaling in bone metastasisEstefania Labanca, Elba S Vazquez, Paul G Corn, et al.
The Prostate|April 19, 2023
Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration-resistant prostate cancerIoulia Vardaki, Seda Sabah Özcan, Pedro Fonseca, et al.
American Journal of Cancer Research|April 1, 2021
Genome-wide DNA methylation profiling of leukocytes identifies CpG methylation signatures of aggressive prostate cancerYuyan Han, Mutian Zhang, Junfeng Xu, et al.
BJU International|March 9, 2011
Maximizing outcomes in genitourinary cancers across the treatment continuumJohn M Fitzpatrick, Joaquim Bellmunt, Robert Dreicer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomySara S Strom, Xuemei Wang, Curtis A Pettaway, et al.
Oncogene|December 3, 2003
A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cellsKevin B Spurgers, Kevin R Coombes, Raymond E Meyn, et al.
Pageof 26

Showing results (61-70 of 251) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2002
Cisplatin, gemcitabine, and ifosfamide as weekly therapy: a feasibility and phase II study of salvage treatment for advanced transitional-cell carcinomaLance C Pagliaro, Randall E Millikan, Shi-Ming Tu, et al.
Journal of the National Cancer Institute|January 19, 2019
Radium 223-Mediated Zonal Cytotoxicity of Prostate Cancer in BoneEleonora Dondossola, Stefano Casarin, Claudia Paindelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 26, 2008
Phase III trial of androgen ablation with or without three cycles of systemic chemotherapy for advanced prostate cancerRandall E Millikan, Sijin Wen, Lance C Pagliaro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 11, 2004
Early predicted time to normalization of tumor markers predicts outcome in poor-prognosis nonseminomatous germ cell tumorsKarim Fizazi, Stéphane Culine, Andrew Kramar, et al.
Endocrine-Related Cancer|May 6, 2020
Fibroblast growth factors signaling in bone metastasisEstefania Labanca, Elba S Vazquez, Paul G Corn, et al.
The Prostate|April 19, 2023
Transcriptomic analysis of plasma exosomes provides molecular information of response to cabazitaxel treatment in men with metastatic castration-resistant prostate cancerIoulia Vardaki, Seda Sabah Özcan, Pedro Fonseca, et al.
American Journal of Cancer Research|April 1, 2021
Genome-wide DNA methylation profiling of leukocytes identifies CpG methylation signatures of aggressive prostate cancerYuyan Han, Mutian Zhang, Junfeng Xu, et al.
BJU International|March 9, 2011
Maximizing outcomes in genitourinary cancers across the treatment continuumJohn M Fitzpatrick, Joaquim Bellmunt, Robert Dreicer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 6, 2005
Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomySara S Strom, Xuemei Wang, Curtis A Pettaway, et al.
Oncogene|December 3, 2003
A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cellsKevin B Spurgers, Kevin R Coombes, Raymond E Meyn, et al.
Pageof 26